Your browser doesn't support javascript.
loading
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
Ramos, Carlos A; Ballard, Brandon; Zhang, Huimin; Dakhova, Olga; Gee, Adrian P; Mei, Zhuyong; Bilgi, Mrinalini; Wu, Meng-Fen; Liu, Hao; Grilley, Bambi; Bollard, Catherine M; Chang, Bill H; Rooney, Cliona M; Brenner, Malcolm K; Heslop, Helen E; Dotti, Gianpietro; Savoldo, Barbara.
Afiliação
  • Ramos CA; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Ballard B; Department of Medicine.
  • Zhang H; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Dakhova O; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Gee AP; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Mei Z; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Bilgi M; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Wu MF; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Liu H; Biostatistics Shared Resource, Dan L. Duncan Cancer Center, and.
  • Grilley B; Department of Medicine.
  • Bollard CM; Biostatistics Shared Resource, Dan L. Duncan Cancer Center, and.
  • Chang BH; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Rooney CM; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Brenner MK; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, Texas, USA.
  • Heslop HE; Department of Medicine.
  • Dotti G; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Savoldo B; Division of Pediatric Hematology and Oncology, Oregon Health and Science University, Portland, Oregon, USA.
J Clin Invest ; 127(9): 3462-3471, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28805662
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Receptores de Antígenos de Linfócitos T / Linfócitos T / Linfoma Anaplásico de Células Grandes / Antígeno Ki-1 Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Receptores de Antígenos de Linfócitos T / Linfócitos T / Linfoma Anaplásico de Células Grandes / Antígeno Ki-1 Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos